$145.61
00.00%
Pre-Market: Jul 19, 5:08 PM EDT
15 minutes delayed
Comments
Loading...
Sarepta Therapeutics
SRPTNASDAQ
Sarepta Therapeutics (SRPT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sarepta Therapeutics (NASDAQ:SRPT) Stock Quotes, Forecast and News Summary
Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 3.00 / 1.87M |
| Day Range | - - - |
| 52 Wk Range | 55.25 - 173.25 |
| Market Cap | $13.76B |
| P/E Ratio | 338.63 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 51 |
| Short Interest | 10.57% |
| Days to Cover | 2.71 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Sarepta Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sarepta Therapeutics (SRPT) stock?
You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.
Who are Sarepta Therapeutics (SRPT) competitors?
Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
What is the target price for Sarepta Therapeutics (SRPT) stock?
There is no analysis for Sarepta Therapeutics.
What is the forecast for Sarepta Therapeutics (SRPT) stock?
Sarepta Therapeutics has a consensus price target of $186.57.
Current stock price for Sarepta Therapeutics (SRPT)?
The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $145.61 last updated July 19, 2024 at 5:08 PM EDT.
Does Sarepta Therapeutics (SRPT) pay a dividend?
There are no upcoming dividends for Sarepta Therapeutics.
When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?
Sarepta Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Sarepta Therapeutics (SRPT) going to split?
There is no upcoming split for Sarepta Therapeutics.
What sector and industry does Sarepta Therapeutics (SRPT) operate in?
Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.